TELA Bio (TELA) Raw Materials (2023 - 2025)

TELA Bio's (TELA) quarterly Raw Materials came in at $118000.0 in Q4 2025, down 13.24% year-on-year from $136000.0 in Q4 2024, and down 13.24% quarter-over-quarter from $136000.0 in Q4 2024.

TELA Bio (TELA) Raw Materials (2023 - 2025) Analysis & Trends

TELA Bio's Raw Materials history runs 3 years deep, the most recent figure standing at $118000.0 for Q4 2025.

  • On a quarterly basis, Raw Materials fell 13.24% year-over-year to $118000.0 in Q4 2025; TTM through Dec 2025 was $118000.0, a 13.24% decrease from a year earlier, with the FY2025 full-year figure at $118000.0, down 13.24% from the prior year.
  • Raw Materials retreated to $118000.0 in Q4 2025 per TELA's latest filing, from $136000.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $136000.0 in Q4 2024 and bottomed at $60000.0 in Q4 2023.
  • The 3-year median for Raw Materials is $118000.0 (2025), against an average of $104666.7.
  • Across the five-year window, Raw Materials jumped 126.67% in 2024 and decreased 13.24% in 2025, its largest moves.
  • Year by year, Raw Materials stood at $60000.0 in 2023, then soared by 126.67% to $136000.0 in 2024, then fell by 13.24% to $118000.0 in 2025.
  • Per Business Quant, the three latest TELA Raw Materials figures stand at $118000.0 (Q4 2025), $136000.0 (Q4 2024), and $60000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 TELA Bio 40.65 Mn 1.11 Mn 12.52 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 118,000.00
Dec 31, 2024 136,000.00
Dec 31, 2023 60,000.00